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A 7-year-old white boy was referred to us with a history of 3 attacks of hypogastric pain over the previous 2 years and
persistently elevated serum amylase concentrations. At physical examination, he was well with no evidence of clinical abnormalities.
His weight and height were normal. Laboratory diagnostic investigations were all normal except for the presence of Ascaris
lumbricoides in the feces and persistently elevated serum amylase levels. Serum amylase determinations in the family members
were normal in his father and maternal grandmother but elevated in his mother, sister, maternal aunt, and uncle, all of whom
asymptomatic. Macroamylasemia was excluded in the child and in the mother. The finding of persistently elevated amylasemia in
the child and in the other family members spanning 3 generations, and the exclusion of diseases that lead to hyperamilasemia are
consistent with the diagnosis of familial hyperamylasemia. Until now, only 1 similar case has been reported. Familial hyperamylasemia
must be considered in the differential diagnosis of hyperamylasemias in childhood.
DESCRIPTORS: Hyperamylasemia. Amylase. Isoamylases. Macroamylase. Pancreatitis.
There is usually a tendency to sus-
pect pancreatic disease whenever
hyperamylasemia is encountered. How-
ever, there are a number of other con-
ditions where elevation of total serum
amylase may be a finding. These con-
ditions include a long list such as cer-
ebrovascular diseases, respiratory dis-
eases, heart diseases, liver diseases,
acute hypoxemia, cholelithiasis, diabe-
tes mellitus, peptic ulcer, malignant
tumor, renal failure, intra and extra-
abdominal surgeries, trauma, bulimia,
anorexia nervosa, dyslipidemia, macro-
amylasemia, ethnic hyperamylasemia,
chronic nonpathologic hyperamyl-
asemia of pancreatic origin, and famil-
ial hyperamylasemia1-8.
The pancreas and salivary glands
are the two organs that account for al-
most all of the serum amylase activity
in normal persons. Hyperamylasemia
can result either from an increased rate
of entry of amylase into the circulation
and/or from a decreased metabolic
clearance of this enzyme9.
Clink et al.10 described 4 patterns of
hyperamylasemia: 1) pancreatic hyper-
amylasemia, 2) salivary hyperamyl-
asemia, 3) both salivary and pancreatic
hyperamylasemia, and 4) macro-
amylasemia.
Pancreatic hyperamylasemia usu-
ally results from an insult to the pan-
creas or a loss of bowel integrity (inf-
arction or perforation) that enhances
absorption of amylase from the intes-
tinal lumen9.
Salivary hyperamylasemia is ob-
served in conditions that involve the
salivary glands. However, other condi-
tions such as chronic alcoholism, post-
operative states (particularly postco-
ronary bypass), lactic acidosis, diabetic
ketosis, anorexia nervosa or bulimia,
and malignant neoplasms may also
cause salivary hyperamylasemia9,11.
Hyperamylasemia can also occur
without pancreatic and/or salivary in-
volvement from decreased metabolic
clearance of amylase caused by renal
failure or from macroamylasemia9. To-
tal serum amylase alone is not enough
to distinguish these various conditions.
The measurement of salivary or pan-
creatic type isoamylase profiles in
hyperamylasemic sera enhances the di-
agnostic accuracy9-14.
Macroamylasemia is an isolated
biochemical abnormality caused by
aggregation of serum amylase activity
with immunoglobulins producing a
high molecular weight amylase-protein
complex in the serum. It is described
as a frequent but benign cause of
hyperamylasemia that requires no
treatment and has been found to occur
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in a variety of diseases including vari-
ous autoimmune disorders. It can be
diagnosed by the presence of macro-
amylase in the serum and by low urine
amylase concentrations in the presence
of normal renal function 7,15.
Tsianos et al.5 measured total serum
amylase and the pancreatic and salivary
isoamylase activities in 92 individuals
without pancreatic or salivary disease,
divided into 3 ethnic subgroups resident
in the UK, namely native Britons,
Asians, and West Indians. These authors
found that immigrants had higher total
serum amylase activities than the usu-
ally accepted reference range for Brit-
ons. They concluded that these differ-
ences in serum amylase may be geneti-
cally determined and called this condi-
tion ethnic hyperamylasemia.
In 1996, Gullo2 reported on persist-
ent pancreatic hyperamylasemia in 18
young adult patients (10 men and 8
women; mean age 46.7 years; range 25-
66 years) who had no evidence of pan-
creatic disease or history of alcohol abuse
or drug intake. They were followed for
a mean of 7.6 years. No pancreatic dis-
eases appeared during the follow up, and
serum amylase level remained abnor-
mally high with a concomitant elevation
of other pancreatic enzymes (trypsin and
lipase). During follow up, enzyme con-
centrations remained elevated, although
wide fluctuations and occasional tran-
sient normalization were observed. The
author concluded that hyperamylasemia
was a benign entity and called it chronic
nonpathological hyperamylasemia of
pancreatic origin..
In 1997, Cuckow et al.1 reported a
case of a 6-year-old boy who under-
went extensive investigation for recur-
rent abdominal pain and was found to
have persistently raised serum amylase.
Endoscopic retrograde cholangiopan-
creatography was normal, and
macroamylasemia was excluded.
Clearance studies suggested no evi-
dence of a renal tubular defect, and se-
rum lipase concentrations were normal.
Serum amylase concentrations were
found to be raised in other family
members spanning 3 generations, all of
whom were asymptomatic, and the pat-
tern of inheritance was consistent with
an autosomal dominant condition. Both
serum pancreatic and salivary iso-
amylases were raised in the child and
the mother. These authors called this
condition familial hyperamylasemia.
In this paper, we report a very simi-
lar case that, as far as we know, is the
second description of this condition.
Though familial hyperamylasemia is
likely to be rare, it must be added to
the long list of conditions that can in-
clude raised serum amylase levels and
should be considered in the differential
diagnosis of hyperamylasemia.
CASE REPORT
A 7-year-old white boy with a pre-
vious history of having presented, over
the previous 2 years, 3 episodes of ab-
dominal pain and persistently elevated
total serum amylase was referred to our
hospital for further investigation. The
pain was at the hypogastrium, with
each episode lasting about 30 minutes
and resolving after treatment with
antispasmodics. Each of these 3 epi-
sodes of abdominal pain was accom-
panied by vomiting and diarrhea. Be-
tween episodes he was well. At the last
episode of abdominal pain he was ad-
mitted to the referring hospital at
Manaus, capital of a state in northern
Brazil, and his total serum amylase was
found to be elevated: 236 U/dL (nor-
mal range 60-160U/dL). Subsequently,
3 more measurements of total serum
amylase were made on different occa-
sions when the child was asympto-
matic, and the results were 298 U/dL
(normal range 60-160 U/dL), 296 U/dL
(normal range 60-160 U/dL), and 79
U/L (normal range  40 U/L) (Table1).
The child was the product of a full-
term pregnancy and was born by
cesarean delivery. His birth weight was
3.65 kg and height was 51 cm. There
was no reference of consanguinity. As
an infant, he had had no relevant dis-
eases and also had no history of trauma
or repeated or prolonged drug use.
On admission, he was well, without
any complaint or abnormality at physi-
cal examination. His growth was nor-
mal (weight = 25.3 kg; height = 123
cm). The abdomen was soft, non-ten-
der, non-distended, and had no hepat-
osplenomegaly or mass.
Laboratory investigations performed
at our hospital were all normal except
for the presence of Ascaris lumbricoides
in the fecal analysis and raised total se-
rum amylase 139 U/L (normal range 
120 U/L). Two more samples of sera,
taken at different occasions and not dur-
ing the child´s abdominal pain episodes,
were sent to 2 different laboratories for
the determination of total serum amy-
lase. The result of the sample sent to a
private laboratory in São Paulo (Labo-
ratório Fleury) was 320 U/L (normal
range  220 U/L) and the other, sent to
Mayo Medical Laboratories (Rochester,
MN, USA), was 135 U/L (normal range
35-115 U/L) (Table 1).
The normal ranges of serum amy-
lase in the different laboratories men-
tioned above were based on reference
values provided by the companies pro-
ducing the kits and were validated in
a large series of healthy subjects.
Routine hematology, glycemia,
protein electrophoresis, lipid profile,
serum lipase concentrations, liver func-
tion tests, and fecal fat content were all
normal. Clearance studies suggested no
evidence of renal disease. LE cells and
antinuclear antibody were negative.
Urinary amylase and the ratio of amy-
lase clearance to creatinine clearance
were normal. The serum macroamylase
determination performed at Mayo
Clinical Laboratories (Rochester, MN,
USA) was negative (Table 1).
The plain abdominal radiograph
and abdominal ultrasound scan were
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normal. Endoscopic retrograde
cholangiopancreatography showed
normal ductal anatomy with a normal
pancreatobiliary junction.
Family members
Blood was taken from the patient’s
father, mother, sister, maternal grand-
mother, maternal uncle, and maternal
aunt, who were all well, asymptomatic,
and taking no alcohol or regular medi-
cation. They were all white. The ma-
ternal grandfather was deceased, so his
blood sample could not be analyzed.
The father and maternal grandmother
had normal serum amylase levels re-
spectively 112 U/L (normal range  220
U/L- Laboratório Fleury) and 83 IU
(normal range 10-125 IU - laboratory
from the referring hospital at Manaus).
The mother had raised total serum
amylase on 2 occasions: 305 U/L (nor-
mal range  220 U/L - Laboratório
Fleury) and 155 U/L (normal range 35-
115 U/L - Mayo Medical Laborato-
ries). The sister, maternal uncle, and
aunt also had raised concentrations of
total serum amylase, which were re-
spectively 164 U/dL (normal range 60-
160 U/dL), 188 U/dL (normal range
60-160 U/dL), and 211 U/dL (normal
range 60-160 U/dL) (Fig.1). These
determinations were all done at the re-
ferring hospital in Manaus. Serum
macroamylase, measured at Mayo
Medical Laboratories (Rochester, MN,
USA), was also negative in the mother.
DISCUSSION
In our patient, the repeated findings
of raised serum amylase levels led to
exhaustive diagnostic investigation.
However, we could not find evidence
of any obvious pancreatic or salivary
gland disease or of any of the reported
conditions associated with raised se-
rum amylase levels. Diabetes mellitus,
dyslipidemia, renal disfunction, chole-
lithiasis, and liver disease were all ex-
cluded. Only intestinal Ascaris
lumbricoides infection was detected.
Chronic nonpathological hyper-
amylasemia of pancreatic origin2,
originally described in young adults
(mean age 46.7 years; range 25-66
years) and characterized by elevated
serum pancreatic amylase, is an un-
likely diagnosis for our patient because
in this condition, all pancreatic enzyme
levels (amylase, lipase, and trypsin) re-
main elevated. Though we could not
determine trypsin and isoamylase lev-
els, which would have enhanced diag-
nostic accuracy, our patient was a 7-
years-old boy, and his serum lipase
measurements made on 3 different oc-
Table 1 - Laboratory investigations.
Serum amylase 236 U/dL (60-160U/dL)*
298 U/dL (60-160 U/dL)*
296 U/dL (60-160 U/dL)*
79 U/L ( 40 U/L)*
139 U/L ( 120 U/L)**
320 U/L ( 220 U/L)***
135 U/L (35-115 U/L) ****
Macroamylase non detectable ****
Hb 14.1 g/L
Ht 42 %
White blood cell counts 6 000/mm3 (2%;38%;12%;1%;41%; 6%)
Platelets 260 000/mm2
ERS 22 mm/h
Fecal parasites Ascaris lumbricoides
Urine analysis normal
Serum iron 47 g/dL (40-140 g/dL)
Serum iron binding capacity 330 mg/dL (240-508 mg/dL)
Serum lipase 12 U/L; 12 U/L and 15.8 U/L (2-18 U/L)
Glycemia 83 mg%; 88 mg% (80-120 mg%)
Serum urea 34 mg% (10-45 mg%)
Serum creatinine 0.6 mg% (0.4-0.8 mg%)
Total protein 6.9 g/dL (6-8 g/dL)
Albumin 4.8 g/dL (3.5-5.5 g/dL)
1 globulin 0.3 g/dL (0.2-0.4 g/dL)
2 globulin 0.4 g/dL (0.4-0.7 g/dL)
 globulin 0.6 g/dL (0.6-1.2 g/dL)
 globulin 0.8 g/dL (0.7-1.6 g/dL)
Total lipids 480 mg% (400-1000 mg%)
Triglycerides 154 mg% (10-160 mg%)
Cholesterol 111 mg% (< 240 mg%)
HDL cholesterol 32 mg% (30-65 mg%)
LDL cholesterol 42 mg%(< 140 mg%)
Cholesterol/ HDL 3.4 (<4.9)
Urinary amylase 1088 IU/L (170-2000 IU/L)
Urinary creatinine 0.84 g/L
Amylase clearance/creatinine clearance 2.3% (1.2-3.8%)
Fecal fat content absent
AST 10 U/L (< 20U/L)
ALT 12 U/L (< 20 U/L)
 GT 6.2 IU/L (6-26 IU/L)
Alkaline phosphatase 133 IU/ml (7-115 IU/mL)
Antinuclear antibody negative
LE cells negative
Upper digestive endoscopy normal
Plain abdominal radiograph normal
Abdominal ultrasound scan no abnormality
Cholangiopancreatography normal
* results from the referring Hospital at Manaus (Caraway modified method)
** results from our hospital (enzymatic method)
*** results from a private laboratory in São Paulo (Laboratório Fleury - enzymatic method)
**** results from Mayo Medical Laboratories (Rochester, MN,USA)
normal range in parentheses.
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casions were all normal. Furthermore,
there is no evidence that chronic non-
pathological hyperamylasemia of pan-
creatic origin is an inherited condition.
Macroamylasemia is also an un-
likely diagnosis for our patient because
macroamylase was not detected in his
serum.
Cuckow et al.1 described a condi-
tion that they called familial hyper-
amylasemia. It occurred in a of 6-year-
old boy who was found to have persist-
ently raised total serum amylase with-
out evidence of any disease after exten-
sive investigation for recurrent abdomi-
nal pain. Serum amylase concentra-
tions were also found to be raised in
the boy’s other family members span-
ning 3 generations, and the pattern of
inheritance was consistent with auto-
somal dominance.
The patient we described is very
similar to the one reported by Cuckow
et al.1. The total serum amylase con-
centration in our patient was persist-
ently elevated. Raised total serum amy-
lase was also found in 4 of our
patient´s family members. The mater-
nal grandfather was deceased, so his
blood sample could not be analyzed,
and the maternal grandmother had a
normal serum amylase. But since the
patient´s mother, as well as his uncle
and aunt, were all affected, we could
conclude that the maternal grandfather
might have been affected. Thus, our
patient also seems to have inherited
this condition that spanned 3 genera-
tions, and the pattern of inheritance is
also consistent with autosomal domi-
nance.
The total serum amylase concentra-
tions of the patient described by
Cuckow et al.1, as well as those of the
patient’s family members, were only
slightly elevated, though these authors
called the condition familial hyper-
amylasemia. The boy had 4 total serum
amylase determinations, and the results
were: 168 Somogyi U/dL (normal
range 40-160 U/dL); 336 Somogyi U/
dL (normal range 40 -160 U/dL); 226
Somogyi U/dL (normal range 40 - 160
U/dL), and 160 IU/L (normal range 19-
95 IU/L). The patient’s father had a
normal serum amylase of 68 IU/L, and
the brother’ s serum amylase was at the
top of the normal range at 95 IU/L
(normal range 19-95 IU/L). His
mother, half sister, and maternal grand-
father had raised concentrations at 144
IU/l, 138 IU/L, and 112 IU/L respec-
tively. Similarly, the total serum amy-
lase concentrations from our patient as
well as from his family members were
also only slightly elevated.
Like the report of Cuckow et al.1,
we also did not have a uniformity in
the results of measurements of serum
amylase because different kits and
methods were used by the different
laboratories. Since the patient was from
another state of the country, the initial
measurements of his serum amylase, as
well as those of the family members,
were performed in the laboratory from
his original city. However, despite of
the lack of uniformity of the kits, the
elevated serum amylase concentrations
were confirmed by our hospital’s labo-
ratory and also by two other private
laboratories.
In familial hyperamylasemia, de-
scribed by Cuckow et al.1, both pancre-
atic and salivary amylases are elevated.
We could not determine the isoamyla-
ses, which could have enhanced the di-
agnostic accuracy by distinguishing the
origin of the elevated serum amylase,
either pancreatic type isoamylase, sali-
vary type isoamylase, or both. How-
ever, we think that our patient pre-
sented many indications that are con-
sistent with the diagnosis of familial
hyperamylasemia. These indications
include age group, slightly raised se-
rum amylase levels, exclusion of dis-
eases that lead to hyperamylasemia,
normal serum lipase, no macro-
amylasemia, and autosomal dominant
inheritance.
Since the first description of famil-
ial hyperamylasemia as a distinct en-
tity in children made by Cuckow et al.1
in 1997, no more cases have been re-
ported. As far as we know, this is the
second description of this condition.
Familial hyperamylasemia must be
considered in the differential diagnosis
of hyperamylasemias in childhood.
Knowledge of this disorder may avoid
unnecessary diagnostic investigations
and/or erroneous treatment of pancrea-
titis because of the presence of hyper-
amylasemia.
Figure 1 - Family Pedigree.
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RESUMO RHCFAP/3073
KODA YKL e col. – Hiperamilasemia
familiar. Rev. Hosp. Clín. Fac.
Med. S. Paulo 57(2):77-82, 2002.
Paciente branco, masculino, sete
anos, encaminhado com história de três
episódios de dor abdominal no baixo
ventre nos últimos dois anos e níveis
elevados de amilase sérica. Ao exame fí-
sico encontrava-se em bom estado ge-
ral, com desenvolvimento pondo-
estatural normal e sem sinais ou sinto-
mas de quaisquer anormalidades clíni-
cas. Os exames complementares para
investigação diagnóstica revelaram-se
todos normais com exceção do exame
parasitológico de fezes que revelou
Ascaris lumbricoides e dos níveis
séricos de amilase que se encontravam
persistentemente elevados. Amilasemias
realizadas nos familiares, todos assinto-
máticos, mostraram níveis normais no
pai e na avó materna e elevados na mãe,
na irmã , na tia e no tio maternos.
Macroamilasemia foi excluída na crian-
ça e na mãe. O encontro de níveis
séricos de amilase persistentemente ele-
vados na criança e nos familares até três
gerações e a exclusão de outras doen-
ças que cursam com aumento da
amilase sérica são consistentes com o di-
agnóstico de Hiperamilasemia Familiar.
Até o presente momento, somente um
caso semelhante foi descrito na literatu-
ra. Hiperamilasemia Familiar deve ser
lembrada no diagnóstico diferencial das
hiperamilasemias em crianças.
DESCRITORES: Hiperamilase-
mia. Amilase. Isoamilases. Macro-
amilase. Pancreatitis.
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